Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

908 Devices (MASS) Receivables - Other (2020 - 2025)

Historic Receivables - Other for 908 Devices (MASS) over the last 5 years, with Q3 2025 value amounting to $3.5 million.

  • 908 Devices' Receivables - Other changed N/A to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year change of. This contributed to the annual value of $400000.0 for FY2022, which is 10000.0% up from last year.
  • As of Q3 2025, 908 Devices' Receivables - Other stood at $3.5 million.
  • Over the past 5 years, 908 Devices' Receivables - Other peaked at $3.5 million during Q1 2025, and registered a low of $55000.0 during Q1 2021.
  • Moreover, its 4-year median value for Receivables - Other was $177000.0 (2021), whereas its average is $743250.0.
  • Per our database at Business Quant, 908 Devices' Receivables - Other soared by 26363.64% in 2022 and then plummeted by 6666.67% in 2023.
  • Quarter analysis of 4 years shows 908 Devices' Receivables - Other stood at $200000.0 in 2021, then surged by 100.0% to $400000.0 in 2022, then crashed by 75.0% to $100000.0 in 2023, then surged by 3400.0% to $3.5 million in 2025.
  • Its last three reported values are $3.5 million in Q3 2025, $3.5 million for Q1 2025, and $100000.0 during Q2 2023.